FDA begins process that could authorize Pfizer vaccine for 5-11 year olds
On Tuesday, a Food and Drug Administration advisory panel debates whether to recommend the Pfizer COVID-19 vaccine to kids between ages 5 to 11. Full authorization could come by the end of the week.
We get the latest from NPR’s Allison Aubrey.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.